Reduced miR-485-5p expression predicts poor prognosis in patients with gastric cancer.
The present study was designed to explore expression and prognostic value of miR-485-5p in patients with gastric cancer. We determined the expression level of miR-485-5p in 132 cases of paired GC and adjacent non-tumor tissues by quantitative real-time PCR (qRT-PCR). The relevance of miR-485-5p expression to the clinicopathological factors was assessed. Overall survival (OS) was examined using Kaplan-Meier curves and the Cox proportional hazards regression model. The expression of miR-485-5p was significantly down-regulated in GC tissues compared with adja-cent normal tissues (p < 0.01). MiR-485-5p expression was positively correlated with larger tumor size (p = 0.003), deeper invasion depth, (p = 0.005), positive lymph node metastasis (p = 0.039), advanced tumor-node-metastasis (TNM) stage (p = 0.017). Patients survival analysis showed that a clear positive correlation between miR-485-5p expression level and survival time of gastric cancer patients (p < 0.001). Multivariate analyses confirmed that a low level of miR-485-5p expression was an independent predictor of poor prognosis in GC patients. Expression level of miR-485-5p serves as a novel biomarker for the overall survival of patients with gastric cancer.